A first-in-human phase 1 study of ABBV-525, a small-molecule MALT1 inhibitor, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma Meeting Abstract
| Authors: | Sochacki, A. L.; Burger, J. A.; Ludwig, C.; Assaily, W.; Munasinghe, W.; Pappano, W.; Greenberg, E.; Will, C.; Thompson, M. C. |
| Abstract Title: | A first-in-human phase 1 study of ABBV-525, a small-molecule MALT1 inhibitor, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 3101 |
| Language: | English |
| ACCESSION: | WOS:001159740302210 |
| DOI: | 10.1182/blood-2023-181671 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
